That’s the view of analysts at Jefferies, who suggest it could “re-ignite concerns over the use of lentiviral vectors and the risk of secondary (vector ... leukaemia (AML) and another of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback